banner_CCC_v2_slim-01.jpg
 

Participants

Participants at the Convergence Forum include an invitation-only group of company founders, senior level executives, investors and healthcare leaders along with a select group of service providers who sponsor the program.  Request an invitation  or call us at 617-437-1400 if you would like to join us.

Companies represented at the 2019 Convergence Forum include:

 

AbbVie
Acorda Therapeutics
Adastra Pharmaceuticals
Adv. Regenerative Manufacturing Instit.
Akcea Therapeutics
Akili Interactive Labs
Alexandria Real Estate Equities
Alnylam Pharmaceuticals
Ambys Medicines
Apic Bio
Aquilo Partners
Arrakis Therapeutics
Artisan Biosciences
Baillie Gifford
BC Platforms
BioCentury
Bloomberg News
Boston Globe
Boston Univ.
Brigham Health
CBT Advisors
Cedilla Therapeutics


Cellino
Cerevance, Inc.
Churchill Pharma LLC
Corvidia Therapeutics
CRISPR Therapeutics
CN Bio Innovations
Comet Therapeutics
CytoSite Biopharma
Eli Lilly & Company
Elstar Therapeutics
EMD Serono
Evelo Biosciences
Foley & Lardner
Frazier Healthcare Partners
GNS Healthcare
GrayBella Capital
Halloran Consulting Group
iCarbonX
Ipsen
Ironwood Pharmaceuticals
IRX Therapeutics
JJDC


Kaleido Biosciences
Koch Institute at MIT
KSQ Therapeutics
Kytopen
Lumira Ventures
Lysosomal Therapeutics
MacDougall Biomedical Communications
Magenta Therapeutics
Merck
Mersana Therapeutics
Mirata Pharmaceuticals
MIT Media Lab
Momenta Pharmaceuticals
MRL Ventures Fund
Navitor Pharmaceuticals
Nocion Therapeutics
Novartis Instit. for Biomedical Rsh.
Oncorus
Ovid Therapeutics Inc.
Oxford Finance LLC
Park Square Executive Search


Pear Therapeutics
Phagelux
Potenza Therapuetics
Prognos
Revolutionary Farms
RMG Associates
Roivant Pharma
Rubius Therapeutics
Sage Therapeutics
Sanofi
Sarepta Therapeutics
Selecta Biosciences
SR One
Stat
Sunovion Pharmaceuticals
The Engine, MIT
Trieza Therapeutics
Twentyeight-Seven
United Neuroscience
Unity Biotechnology
USB
Visterra
Voyager Therapeutics